Breast Cancer: Nuclear Medicine in Diagnosis and Therapeutic OptionsEmilio Bombardieri, Gianni Bonadonna, Luca Gianni Springer Science & Business Media, 2007 M12 22 - 299 páginas There can never be enough material in the public domain about cancers, and particularly breast cancer. This book adds much to the literature. It provides general information on breast cancer management and considers all new methods of diagnosis and therapy. It focuses on nuclear medicine modalities by comparing their results with other diagnostic and therapeutic approaches. The coverage provides readers with up-to-date knowledge on breast cancer as well as information on the advances in the field of diagnosis. It also details data on the development of some new modalities and provides a general overview of the available tools for breast cancer treatment. |
Contenido
| 2 | |
Circulating Tumour Markers in Breast Cancer | 33 |
Breast Imaging with Scintimammography | 57 |
99mTcMIBI in the Evaluation of Breast Cancer Biology | 71 |
State of the Art of Current Modalities for the Diagnosis of Breast Lesions | 99 |
New Trends of MRI in Breast Cancer Diagnosis | 127 |
PET Imaging of Breast Cancer Molecular Biomarkers | 145 |
FDGPET and Tumour Marker Tests for the Diagnosis of Breast Cancer | 189 |
PETCT and Breast Cancer | 217 |
Progress in the Treatment of Early and Advanced Breast Cancer | 239 |
186ReHEDP for Metastatic Bone Pain in Breast Cancer Patients | 257 |
153SmEDTM for Bone Pain Treatment in Skeletal Metastases | 271 |
| 293 | |
Otras ediciones - Ver todas
Breast Cancer: Nuclear Medicine in Diagnosis and Therapeutic Options Emilio Bombardieri,Gianni Bonadonna,Luca Gianni Sin vista previa disponible - 2007 |
Breast Cancer: Nuclear Medicine in Diagnosis and Therapeutic Options Emilio Bombardieri,Gianni Bonadonna,Luca Gianni Sin vista previa disponible - 2010 |
Breast Cancer: Nuclear Medicine in Diagnosis and Therapeutic Options Emilio Bombardieri,Gianni Bonadonna,Luca Gianni Sin vista previa disponible - 2009 |
Términos y frases comunes
accuracy activity analysis assessment associated axillary lymph node biopsy bone bone metastases breast cancer patients breast carcinoma Cancer Res carcinoma cells changes chemotherapy Clin Oncol clinical combination compared considered correlation demonstrated detection diagnostic disease dose early effect et al evaluation evidence examination expression factors FDG-PET findings follow-up glucose hormonal identified imaging important improve increased indicate invasive involvement Italy lesions levels limited locally malignant mammography markers measurement metastases method monitoring negative Nucl Nucl Med nuclear medicine Oncology P-glycoprotein pain pathological performed PET/CT phase positive positron emission possible predictive present primary procedures prognostic recent recurrence reduce reported response risk role scan scintigraphy screening sensitivity sentinel showed significant SLNB specificity SPECT staging status Surg surgery technique therapy tion tissue treated treatment trial tumour tumour marker uptake women